Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
about
Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic HypertensionThe CUL3/KLHL3-WNK-SPAK/OSR1 pathway as a target for antihypertensive therapyHypertension: the missing WNKs.Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.WNK signalling pathways in blood pressure regulationPPARγ Regulation in Hypertension and Metabolic Syndrome.ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.Ubiquitination and the Regulation of Membrane Proteins.Genetic screening in arterial hypertension.Potassium depletion stimulates Na-Cl cotransporter via phosphorylation and inactivation of the ubiquitin ligase Kelch-like 3.A cullin 4B-RING E3 ligase complex fine-tunes pancreatic δ cell paracrine interactions.Mutant Cullin causes cardiovascular compromise.Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.Potassium-Regulated Distal Tubule WNK Bodies are Kidney-Specific WNK1 Dependent.The evolving field of salt transport regulation in the Steve Hebert Lecture.Renal Tubular Ubiquitin-Protein Ligase NEDD4-2 Is Required for Renal Adaptation during Long-Term Potassium Depletion.Mechanisms and controversies in mutant Cul3-mediated Familial Hyperkalemic Hypertension.New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.
P2860
Q36414701-4D8853D2-A4F9-4D48-A73C-2B5FF52E8DE7Q37072434-7FF45C65-9855-4DE1-AC28-408234748712Q37139457-DDF9D6BF-8B62-4B0E-8E1D-9D4DDA8D16AFQ37417507-2511204C-4799-4CC1-AC3F-3CABA9C788E6Q37694287-A9C3B404-D625-4816-9BAD-AEB753205B27Q38606230-4AA02CDE-87C8-4338-B7D1-2A6798591B16Q38759831-5591633B-D084-4CF3-BF67-692D67F85A7CQ38791699-622EEB42-62D6-4BF0-83BE-5F9152C68F50Q39033646-B25B40F4-1271-43F1-9E86-8680F3AE445AQ39069812-869E1F8A-4B93-4E33-B70F-A2AFE0E83B7DQ39110215-A12D7D21-05B4-4D86-BE71-26D75ABCE0DFQ41661662-3B6B158E-40A5-4D57-8C63-1FE24AE0AB20Q41810410-CCFD4BB1-0C05-46B4-B644-A6D8BED20014Q47269007-220A3A56-7288-404E-81BD-F544EE0D4A91Q47296379-C9CF6155-A98A-4F04-A13D-027A11086769Q48511645-33051CF3-BDB4-44FE-B8DC-1911C33CF200Q50803754-7907C3F5-B006-4DB7-8AB6-EB903248D5B8Q52390102-F6F87BD4-4398-4DA1-A87F-0E9C0B9E1941Q52644438-C0F3DBAC-D186-4CCB-9E23-2017FBAEB609
P2860
Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@ast
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@en
type
label
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@ast
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@en
prefLabel
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@ast
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@en
P2093
P2860
P50
P356
P1476
Characterisation of the Cullin ...... ypertension and hyperkalaemia.
@en
P2093
Axel Knebel
Clare Johnson
Frances-Rose Schumacher
James T Ferryman
Jinwei Zhang
Kevin M O'Shaughnessy
Nichola L Figg
Radoslav Enchev
Raya S Al Maskari
Sarah E Cleary
P2860
P304
P356
10.15252/EMMM.201505444
P577
2015-08-18T00:00:00Z